Literature DB >> 23349220

3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry.

Smitha Rajaram1, Andrew J Swift, Adam Telfer, Judith Hurdman, Helen Marshall, Eleanor Lorenz, David Capener, Christine Davies, Catherine Hill, Charlie Elliot, Robin Condliffe, Jim M Wild, David G Kiely.   

Abstract

BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of pulmonary embolism potentially curable by surgery. Perfusion scintigraphy is currently advocated as the imaging modality of choice to exclude CTEPH due to its high sensitivity. We have evaluated the diagnostic utility of lung perfusion MRI.
METHODS: Consecutive patients attending a pulmonary hypertension referral centre undergoing lung perfusion MRI, perfusion scintigraphy, CT pulmonary angiography (CTPA) and right heart catheterisation within 14 days were identified.
RESULTS: Of 132 patients, 78 were diagnosed as having CTEPH. Lung perfusion MRI correctly identified 76 patients as having CTEPH with an overall sensitivity of 97%, specificity 92%, positive predictive value 95% and negative predictive value 96% compared with perfusion scintigraphy (sensitivity 96%, specificity 90%) and CTPA (sensitivity 94%, specificity 98%). No cases of surgically accessible CTEPH were missed with either modality.
CONCLUSIONS: Lung perfusion MRI has high sensitivity equivalent to perfusion scintigraphy in diagnosing CTEPH but does not require ionising radiation, making it an attractive initial imaging modality to assess patients with suspected CTEPH.

Entities:  

Keywords:  Imaging/CT MRI etc

Mesh:

Year:  2013        PMID: 23349220     DOI: 10.1136/thoraxjnl-2012-203020

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  30 in total

Review 1.  Chronic thromboembolic pulmonary hypertension.

Authors:  Karen M Olsson; Bernhard Meyer; Jan Hinrichs; Jens Vogel-Claussen; Marius M Hoeper; Serghei Cebotari
Journal:  Dtsch Arztebl Int       Date:  2014-12-12       Impact factor: 5.594

2.  Structural and perfusion magnetic resonance imaging of the lung in cystic fibrosis.

Authors:  Christina Amaxopoulou; Ralph Gnannt; Kai Higashigaito; Andreas Jung; Christian J Kellenberger
Journal:  Pediatr Radiol       Date:  2017-11-15

3.  Cardio-pulmonary MRI for detection of treatment response after a single BPA treatment session in CTEPH patients.

Authors:  Christian Schoenfeld; Jan B Hinrichs; Karen M Olsson; Martin-Alexander Kuettner; Julius Renne; Till Kaireit; Christoph Czerner; Frank Wacker; Marius M Hoeper; Bernhard C Meyer; Jens Vogel-Claussen
Journal:  Eur Radiol       Date:  2018-10-11       Impact factor: 5.315

Review 4.  Evaluation and classification of pulmonary arterial hypertension.

Authors:  Sandeep Sahay
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

Review 5.  Chronic pulmonary embolism: diagnosis.

Authors:  Katia Hidemi Nishiyama; Sachin S Saboo; Yuki Tanabe; Dany Jasinowodolinski; Michael J Landay; Fernando Uliana Kay
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 6.  Imaging of pulmonary hypertension: an update.

Authors:  Harold Goerne; Kiran Batra; Prabhakar Rajiah
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 7.  "Structure-Function Imaging of Lung Disease Using Ultrashort Echo Time MRI".

Authors:  Luis Torres; Jeff Kammerman; Andrew D Hahn; Wei Zha; Scott K Nagle; Kevin Johnson; Nathan Sandbo; Keith Meyer; Mark Schiebler; Sean B Fain
Journal:  Acad Radiol       Date:  2019-01-16       Impact factor: 3.173

Review 8.  Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes.

Authors:  David S Poch; William R Auger
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 9.  Chronic Thromboembolic Pulmonary Hypertension: Pearls and Pitfalls of Diagnosis.

Authors:  Humna Abid Memon; C Huie Lin; Ashrith Guha
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

Review 10.  Advances in the management of chronic thromboembolic pulmonary hypertension.

Authors:  Demosthenes G Papamatheakis; Nick H Kim
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.